Increasing Trauma Cases to Drive Growth of Global Synthetic Blood Substitutes Market

A new report from Transparency Market Research, titled ‘Synthetic Blood Substitutes Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,’ states that the growth of the global synthetic blood substitutes market is propelled by the increasing cases of trauma including road accidents, burns, and military wars. The rise in the aging population has resulted in the growing need for surgical interventions such as cardiac surgeries, blood cancer treatment, and others. All these factors are expected to propel the global synthetic blood substitutes market in the next few years.

Download Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2005

The key use of blood substitutes is to deliver a temporary support to the blood circulation system whenever required. Blood substitutes are used in situations such as surgeries or blood transfusions wherein the former are used for transporting oxygen for a specific duration. Among the blood substitutes available on the global market are hemoglobin-based oxygen carriers and perfluorocarbons (PFC) emulsions. The perfluorocarbons are primarily derived from a specific group of hydrocarbons wherein fluorine atoms replace the hydrogen atoms. This has been very beneficial in the creation of artificial blood at the time of surgeries.

Perflubron and perfluorodecalin are two of the most common PFCs. The most important advantage of PFCs is that they allow the easy transportation of oxygen throughout the body. However, one of the common side effects of PFCs is the decrease in the platelet counts. However, an excess of PFCs may also cause flu-like symptoms in the body. Hemoglobin-based oxygen carriers are successfully used to imitate the duty of oxygen carriers to carry hemoglobin in the body. People who frequently use synthetic blood substitutes may have to deal with anaphylactic shock. Irrespective of research and development activities, there is still a big gap in meeting the basic safety requirements for using synthetic blood substitutes. These factors are expected to hamper the growth of the global synthetic blood substitutes market in the years to come.

However, the leading companies in the global synthetic blood substitutes market are constantly focusing on the introduction of new biotechnological techniques to develop and introduce effective synthetic blood substitutes. For instance, OPK Biotech, a leading company in the global synthetic blood substitutes market, managed to develop a hemoglobin-oxygen-based blood carrier through the chemical stabilization of bovine hemoglobin. This innovative product, Hemopure, is being sold in South Africa. The introduction of many such products is expected to contribute towards the growth of the global synthetic blood substitutes market in the years to come.

Browse Report: http://www.transparencymarketresearch.com/synthetic-blood-substitutes.html

By geography, the global synthetic blood substitutes market is divided into Europe, Asia Pacific, North America, and Rest of the World. Biopure (Hemopure), Sangart, Northfield (Polyheme), and Dendritech are some of the leading players in the global synthetic blood substitutes market.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.